Our 2020 Spring Request for Applications has opened; find a PDF with instructions here.

Pertinent info for the current RFA:
- Deadline Pre-Proposals: Wednesday February 12, 2020 - by midnight
- Full proposals will be sollicited from selected PIs by February 24th
- Deadline full proposals will be March 16, 2020
- Awards are for 2 years, $50,000 per year 
- All UAB faculty and SR scientists are eligible to apply
- Only small molecule-directed efforts are considered responsive to this RFA

The ADDA offers pilot funding opportunities in collaboration with, Southern Research, the UAB School of Medicine, the UAB Center for Clinical and Translational Science and with the UAB Comprehensive Cancer Center. Grants are for $50,000 per year for 2 years, with the second year of funding dependent on progress made in the first year. Funds can be utilized for any aspect of drug discovery and development, including - but not limited to - assay development for high-throughput screening, molecular modeling and medicinal chemistry efforts, or proof of concept studies in animals with newly discovered lead molecules. Upon funding, a multi-disciplinary team will be assembled, consisting of members with relevant expertise, including cell biology, pharmacology, medicinal chemistry, HTS assay development as well as clinical knowledge. This team, which will meet quarterly, will help create a compound progression pathway and guide the project through the drug discovery and development pipeline. In addition to scientific merit, applications will be evaluated for intellectual property and commercialization aspects, in collaboration with the Bill L. Harbert Institute for Innovation and Entrepreneurship (IIE) and Southern Research.